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Association of HLA-DRw8 and DQw3 with minimal change nephrotic
syndrome in Japanese adults. The HLA systems of forty Japanese
patients with adult-onset nephrotic syndrome and biopsy-proven mini-
mal change were investigated. HLA-DRw8 was found in 35% of the
patients and HLA-DQw3 in 95%, compared to 12.6 and 63.1% of the
control, respectively (DRw8: and Pc <0.01, RR = 3.74; DQw3: Pc <
0.02, RR = Iii). The phenotype frequencies of all but one HLA-DR
antigens, DR4, DR5, DRw8, and DRw9 associating with DQw3, were
observed to increase (patient vs. control: DR4, 65 vs. 4 1.4%; DR5, 10
vs. 4.3%; DRw9, 20 vs. 23%). These results suggest that HLA-DQw3
may be a primary genetic marker associated with a major susceptibility
gene to adult-onset minimal change nephrotic syndrome in the Japanese
population.
Association de HLA-DRw8 et DQw3 au syndrone nephrotique a lesions
glomerulaires minimes chez des adultes japonais. Le système HLA de
quarante malades japonais atteints de syndrome ndphrotique apparu a
l'age adulte, et dO h des lesions glomerulaires minimes prouvdes par Ia
biopsie, a été étudié. HLA-DRw8 a été trouvé chez 35% des malades,
et HLA-DQw3 chez 95%, par rapport a 12.6 et 63,1% chez les
contrôles, respectivement (DRw8: Pc < 0,01, RR = 3,74; DQw3: Pc <
0,02, RR = 11,1.). Les frequences phenotypiques de tolls les antigenes
HLA-DR saufun, DR4, DR5, DRw8, et DRw9 s'associant a DQw3, ont
été trouvées augmentées (malades par rapport aux contrOles: DR4, 65
contre 41,4%; DR5, 10 contre 4,3%; DRw9, 20 contre 23%). Ces
résultats suggèrent que HLA-DQw3 pourrait étre un marqueur
gCnétique prirnitivement associé a une susceptibilite génetique majeure
lors du syndrome néphrotique a lesions glomerulaires minimes apparu
chez l'adulte japonais.
Minimal change nephrotic syndrome (MCNS), generally
called lipoid nephrosis, is the most common glomerular disor-
der in child patients with nephrotic syndrome. In adults, too,
this condition is recognized not infrequently as a causative
disease of primary nephrotic syndrome, encountered in about
one-third of such patients, while another one-third shows
membranous nephropathy and the remaining one-third prolifer-
ative glomerulonephritis, such as membranoproliferative gb-
merubonephritis and IgA nephropathy [1].
Recently, several observations have suggested immunologi-
cal mechanisms for this disease. An increased incidence of
allergic diseases in children with MCNS is recognized and
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serum levels of IgE are seen to be elevated in this disease [2—4].
Evidence of circulating immune complexes is found in some
patients with MCNS [5]. A close association of MCNS with
Hodgkin's disease—a malignancy involving T-lymphocytes—is
indicated [61. In some studies, the blastogenesis of lymphocytes
from patients with MCNS in relapse in response to mitogens
such as phytohemagglutinin (PHA) and concanavalin A (Con A)
is decreased more markedly when cultured in nephrotic sera
than in normal sera [7, 8]. Furthermore, it is suggested that the
alterations of glomerular permeability in MCNS are produced
by a circulating lymphokine [9].
Some diseases with an immunological basis are known to be
associated with major histocompatibility complexes (MHC)
[10]. Previously, we have reported the association of the HLA
system with IgA nephropathy [11] and membranous nephrop-
athy [12]. In children with steroid-responsive nephrotic syn-
drome, an increased frequency of the HLA-B12 antigen was
observed initially [2], and thereafter the HLA-DR7 was found
to be associated strongly [13]. In adults with this disease,
however, such associations have never been reported. In this
study, the correlation between the HLA system and adult-onset
MCNS was investigated.
Methods
Patients
During the 12-year period since 1972, 62 patients with adult-
onset nephrotic syndrome were diagnosed as MCNS by renal
biopsy. Biopsy specimens were studied by light, electron, and
immunofluorescent microscopies. In all cases, a histological
evidence of focal segmental glomerular sclerosis was not found.
All patients were over 15 years old when they showed a sudden
onset of nephrotic syndrome. The diagnosis of nephrotic syn-
drome was described previously [12]. None of them had
hematuria, hypertension, renal dysfunction, or hypocomple-
mentemia throughout the course of the disease. All of them
exhibited good responsiveness to steroids, which was indicated
by a rapid fall in proteinuria to 0.2 glday or less. This degree of
response was seen again without fail at times of relapse.
Of the 62 patients, 40 individuals selected randomly became
the subjects of this study. All 40 subjects were progressing
toward a complete remission at the time of investigation.
Eighteen of the 40 patients had only a single episode of
nephrotic syndrome during the follow-up period and, in all of
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the 18, steroid treatment had already been stopped at the time
of investigation. In another 22 patients, one or more relapses
occurred when steroids were tapered or discontinued. In 12 of
the 22 relapsing patients, steroids were completely discontinued
within the first 3 years of follow-up (steroid non-dependent
group). The remaining 10 patients with frequent relapses were
dependent on steroid treatment for more than 3 years after
commencement of steroid treatment (steroid-dependent group).
Nine of these 10 patients were treated with cyclophosphamide
in combination with steroid following the second or third
relapse.
Allergic status was assessed according to the clinical atopic
symptoms of bronchial asthma, eczema, urticaria, drug and
food allergy. Only six patients had a positive allergic status.
Since IgE and IgE antibody data were incomplete in more than
half of the patients, they were not assessed in the present study.
The clinical features of the 40 patients are summarized in Table
1.
HLA typing and statistical analyses
The HLA-A, B, DR, and DQ antigens were determined by
the standard microlymphocyte toxicity test of Mittal et al [141.
B cell for HLA-DR and DQ typing were separated by a nylon
wool column [151. Antisera, defining 16 A, 30 B, 11 DR, and 2
DQ antigens, were obtained from Dr. P. I. Terasaki of the
University of California, Los Angeles, Tissue Typing Labora-
tory. The frequencies of normal control in HLA-A, B, and DR
loci were those referred to in the report of Baur and Danilovs
included in the Vilith International Histocompatibiity Work-
shop [161. We used normal control frequencies from our own
laboratory for the HLA-DRw52, 53, and DQ system.
Statistical analyses were performed by the chi-square test
and Fisher's exact test. To avoid a false positive, all x2analyses
were corrected according to Yates' method. Further, P values
were multiplied by 59, which was the total number of antigens
(corrected P), according to the method of Svejgaard et al [171.
We considered it to be statistically significant if the corrected P
value (Pc) was less than 0.05. The relative risk (RR) was
determined by the method of Svejgaard et a! [17].
Results
Table 2 represents the phenotype frequencies of HLA-A, B,
DR, and DQ antigens in the patient group as well as in the
control. There were much higher frequencies of HLA-DRw8
and DQw3 in the patient group than those in the control group.
Both differences between the two were statistically significant
(DRw8: 35 vs. 12.6%, Pc < 0.01, RR = 3.74; DQw3: 95 vs.
63.1%, Pc < 0.02, RR = 11.1). There was also a higher
frequency of HLA-DR4 in the patient group than in the control,
but this difference was not statistically significant (DR4: 65 vs.
41.1%, Pc < 0.31, RR = 2.63). The phenotype frequency of
DRw6 was decreased in the patient group as compared to the
control, but no statistically significant difference was observed
(DRw6: 7.5 vs. 32.9%, Pc <0.10, RR = 0.16). In the HLA-A
and B loci, antigens did not show any significant differences
between the two groups.
The frequencies of HLA-B8, B18, and DR7, regarded to have
an association with MCNS in Caucasian populations, were very
low in both the patient and control groups in the Japanese
population (patient vs. control: B8, 0 vs. 0.2%; B18, 0 vs. 0%;
DR7, 2.5 vs. 1%). The frequency of HLA-B13 in the patient did
not differ from the control series (patient vs. control; 7.5 vs.
4%).
Table 3 shows the phenotype frequencies of HLA-DRw8,
DQw3, and DR4 in each group, classified according to clinical
features. Patient groups with single nephrotic episode or steroid
non-dependency had an increased tendency of HLA-DRw8
(44.4%, 43.3%) and DR4 (77.8%, 73.3%), compared to those
with relapses or steroid dependency, respectively (DRw8:
27.2%, 10%; DR4: 54.5%, 40.4%). A group without allergic
status disclosed a higher frequency of HLA-DRw8 (38.2%),
compared to that with such status (16.6%). These differences,
however, were far from being statistically significant. As for
HLA-DQw3, on the other hand, the phenotype frequencies
were as high as 90 to 100% in each group and, again, there were
no significant differences between each of the two groups.
Discussion
Forty Japanese patients with adult-onset nephrotic syndrome
and biopsy-proven minimal change were investigated concern-
ing their HLA system. The phenotype frequencies of two HLA
antigens, DRw8 and DQw3, in the patient group differed
significantly from the control series. HLA-DR4 in the patients
was also observed at a higher frequency of 65% than that of
41.4% in the control, but this difference did not reach a
statistical significance.
The association of the HLA system with MCNS in children
has been reported from Western countries. In 1976, Thomson et
a! [2] first reported from England that a higher frequency of
HLA-B12 antigen was observed in Caucasian children with
steroid-responsive nephrotic syndrome (SRNS) than in the
control (N = 71, Pc < 0,02, RR = 6.3), and that in children who
have both HLA-B12 and a history of atopy, the risk of devel-
oping SRNS was 13 times greater than in those with neither
factor. In 1980, Trompeter et al [3] described from the same
laboratory that, although the patient population was enlarged
and they again found a higher incidence of HLA-Bl2 in SRNS
children than in the control (N = 116, Pc < 0.05, RR = 3.1), the
association of HLA-B12 with atopy in SRNS children did not
Table 1. Clinical features of MCNS
Number of total patients
Mean age, years
range
Sex, male/female
Total duration of the disease, months
Renal function at remission
Mean Ccr, mi/mm
Hematuria, case (%)
Hypertension, case (%)
(150/90 mm Hg or more)
Nephrotic episode
single, case (%)
two or more (relapse), case (%)
Steroid responsive, case (%)
Steroid dependency, case (%)
non-dependent (discontinued within 3 years)
dependent (for more than 3 years)
Allergic status, case (%)
40
29.1 13.5
15 to 65
16/24
83.8 63.1
99.1 14.8
0 (0%)
0 (0%)
18 (45%)
22 (55%)
40 (100%)
30 (75%)
10 (25%)
6 (15%)
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Table 2. HLA-A, B, DR, and DQ phenotype frequencies in the patients with MCNS and control
Control Patient Control Patient
HLA-A locus N = 949 N = 40 HLA-B locus N = 950 N = 40
A 1 1.1 0.0 Bw49 0.6 0.0
A 2 43.2 42.5 Bw50 0.0 0.0
A 3 1.1 0.0 Bw5l 15.9 10.0
All 17.2 25.0 Bw52 20.5 25.0
Aw23 1.1 0.0 Bw53 0.2 0.0
Aw24 58.5 57.5 Bw54 14.1 22.5
A25 0.1 0.0 Bw55 5.8 10.0
A26 18.7 22.5 Bw56 2.2 0.0
A28 1.1 0.0 Bw57 0.0 0.0
A29 0.4 0.0 Bw58 1.7 0.0
Aw30 0.3 2.5 Bw59 4.2 2.5
Aw31 15.3 15.0 Bw60 12.7 20.0
Aw32 0.1 0.0 Bw61 16.8 25.0
Aw33 13.1 10.0 Bw62 16.7 15.0
Aw34 1.9 0.0 Bw63 0.4 NT
Aw36 0.5 0.0
Aw43 0.0 NT HLA-DR locus N = 884 N = 40
HLA-B locus N = 950 N = 40 DR 1
DR 2
12.2
36.0
5.0
30.0
B 7 11.4 10.0 DR 3 3.2 2.5
B8 0.2 0.0 DR4 41.4 65.0
Bl3 4.0 7.5 DR 5 4.3 10.0
B14 0.2 0.0 DRw6b 32.9 7.5
B18 0.0 0.0 DR 7 1.0 2.5
B27 0.8 2.5 DRw8C 12.6 35.0
Bw35 14.1 7.5 DRw9 23.0 20.0
B37 1.1 0.0 DRwIO 1.2 NT
Bw38 0.4 0.0
Bw39 5.7 12.5 N = 103 N = 40
Bw4l 0.7 0.0 DRw52 39.8 52.5
Bw42 1.2 0.0 DRw53 66.0 75.0
Bw44 12.5 7.5
Bw45 0.3 0.0 HLA-DQ system N = 103 N = 40
Bw47 0.4 0.0 DQwI 49.5 47.5
Bw48 4.6 2.5 DQw3" 63.1 95.0
Antigens x2 P < Pc < RR
DR4 7.8 0.0053 0.31 (NS) 2.63
DRW6b 9.8 0.0017 0.10 (NS) 0.16
DRw8C 14.6 0.00014 0.01 3.74
DQw3d 13.0 0.00032 0.02 11.11
Abbreviations are: NT, not tested; g2, chi-square with Yates' correction; NS, not significant; RR, relative risk.
persist. At the same time, the HLA-B8 antigen was reported to
occur with a significantly high frequency in the patient group,
compared to the control by O'Regan et al [181 from Ireland (N
= 54, 64.8 vs. 34.8%, Pc < 0.01, RR = 3.5) and by Noss,
Bachmann, and Olbing [19] from Germany (N = 45, 42.2 vs.
20,5%, Pc <0.027, RR = 2.81). O'Regan et al also reported that
the increased frequency of HLA-B 18 attained a significance (N
= 54, 18.3 vs. 5.5%, Pc < 0.05, RR = 3.16) and Noss,
Bachmann, and Olbing described the significantly high fre-
quency of HLA-B13 (N = 45,20 vs. 4.3%, Pc <0.001, RR =
4.65), together with HLA-B8, respectively. These associations,
however, of HLA-A and B antigens with MCNS children were
not seen in other studies [13, 20, 21].
In 1980, Alfiler et a! [13] reported initially from Australia that
the incidence of HLA-DRw7 was significantly greater in SRNS
children, in 36 of whom renal biopsy revealed minimal change,
than in the control (N = 42, 71 vs. 29.8%, Pc < 0.005, RR =
5.9). The increased frequency of HLA-DR7 in MCNS has been
confirmed in two successive series of DeMouzon-Cambon et a!
[20] from France and Nunez-Roldan et al [21] from Spain.
Laurent et al [22] from France reported that in 39 adults with
lipoid nephrosis the phenotype frequency of HLA-DR7 was
only 18%, but that if these adult patients were separated
according to the age of onset, HLA-DR7 was observed in five of
11 patients with onset before 15 years old (45%), while only in
two of 28 patients with adult onset after 15 years old (7%) (P =
0.024). Recently, Tejani et a! [23] reported that the presence of
HLA-DRwS was observed in six of eight nephrotic children
with focal glomerulosclerosis (FGS) in three unrelated Hispanic
families. But this association of HLA-DRw8 with FGS must be
considered with caution because the sample size was very
small.
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Table 3. HLA-DRw8, DQw3, and DR4 phenotype frequencies in each
group classified by clinical features
N DRw8 DQw3 DR4
Nephrotic episode
Single
Two or more
18
22
44.4% 'NS
27.2%
100% NS
90.9%
77.8% NS
54.5%
Steroid dependency
Non-dependent
Dependent
30
10
43.3% (NS
10%
6o 'NS
90% NS40%
Allergic status
Present
Absent
6
34
16.6% NS
38.2% '
100% NS
94.1% '
66.6%
64.7%
N = number of patients. NS, not significant (Fisher's exact test).
In the present study, HLA-DRw8 was found to have a
significant association with adult-onset MCNS. The difference
of HLA antigens between Caucasian and Japanese patients with
MCNS is difficult to explain, but may result in part from racial
and/or geographical differences in the distribution of HLA
antigens. Further, the possibility may exist that HLA-DRw8 in
Japanese and HLA-DR7 in Caucasians possess the linkage
disequilibrium with a similar unknown gene that has a suscep-
tibility to MCNS, as speculated previously in the case of
idiopathic membranous nephropathy [12]. In the Japanese
population, HLA-DR7 is very low in its frequency, as this paper
confirms.
Recent genetic and serological data indicate that the human
MHC encodes multiple DR like antigens. Of particular interest
are several series of serological specificities expressed on B cell
found in linkage disequilibrium with various DR specificities.
These have been termed DC [24], MB [25], and MT [26]
antigens. Very recently, new HLA-DQ specificities consisted of
DQw1, DQw2, and DQw3 were defined instead of DC, MB, and
MT antigens in the IXth International Histocompatibility Work-
shop held in 1984 [27]. It is possible that the DQ antigens are the
allelic products of a locus distinct from, but linked closely to,
the HLA-DR [27]. Based on the serological data, HLA-DQw3
was found in association with HLA-DR4, DR5, DRw8, and
DRw9 [271. In the present study, HLA-DQw3 was shown to
associate strongly with MCNS patients, and, moreover, the
phenotype frequencies of all but one HLA-DR antigens associ-
ating with DQw3 were found to increase. The phenotype
frequencies of HLA-DRw9 in patients and the control were
almost equal, 23 vs. 20%. These results suggest that HLA-
DQw3 may be a primary genetic marker associated with a major
susceptibility gene to adult-onset MCNS in the Japanese pop-
ulation, and that the increased frequencies of HLA-DR antigens
associating with DQw3, including HLA-DRw8, may be a sec-
ondary association due to a linkage disequilibrium between
HLA-DQ and DR antigens. However, the possibility that
HLA-DRw8 and DQw3 respectively may have a linkage
disequilibrium to an unknown susceptibility gene to MCNS
cannot be denied.
No relapsing cases or steroid non-dependent cases showed
higher frequencies in HLA-DRw8 and DR4 than those with
relapses or steroid dependency. Thus, good responders to
steroid therapy showed a trend toward an increased presence of
HLA-DRw8 and DR4, although these differences between the
two groups did not reach a statistical significance in any of the
cases studied. Also, the data did not point to any relationship
between the incidence of HLA-DRw8 or DR4 and the presence
of any clinically defined allergic status. The relationship be-
tween the incidence of HLA antigens of any kind and atopic
status in MCNS is still controversial [2, 13, 20]. HLA-DQw3,
on the other hand, showed high and quite similar frequencies
among the groups. Again, these results suggest that HLA-
DQw3 may be in a primary association with the MCNS studied.
In conclusion, the definite association of HLA-DRw8 and
DQw3 with the MCNS studied suggests that some im-
munogenetic situation may be responsible for the immunologi-
cal mechanisms in the occurrence of Japanese adult-onset
MCNS.
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